JACC: CardioOncology Video Case Presentation | Early Immune Checkpoint Inhibitor Cardiotoxicity

JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted TherapyПодробнее

Advanced Cardiac Imaging Among Patients with Cardiovascular Complications From Cancer ImmunotherapyПодробнее

JACC: CardioOncology Virtual Journal Club | June 30, 2020Подробнее

CV Impact of Immune Checkpoint Inhibitor CardiotoxicityПодробнее

What You Should Know About Cardio OncologyПодробнее

Cardiac Troponins and Checkpoint InhibitorsПодробнее

7) ATRIUM Trial Blood ProcessingПодробнее

Immune-mediated mechanisms in checkpoint inhibitor-induced myocarditisПодробнее

Cardio-Oncology in 2019Подробнее

JACC: CardioOncology Virtual Case Presentation Series: Amyloidosis | Part TwoПодробнее

Cancer Immune Checkpoint InhibitorsПодробнее

Cardio-Oncology Impatient ConsultsПодробнее

Drs. Ky and Witteles Discuss the Amyloidosis Special Issue | JACC: CardioOncologyПодробнее

Role of Cardioprotection in Cancer Therapy Cardiotoxicity | JACC: CardioOncology Author DiscussionПодробнее

Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Medicine Grand Rounds: "Cardio-Oncology: A New Frontier" 1/31/2023Подробнее

Cardiac toxicity of immune-checkpoint inhibitors – ID 185202Подробнее